Aculys Pharma is a series b startup. 2 investors tracked. Status: possibledead.
Aculys Pharma is a company founded in 2021 headquartered in Japan. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Aculys Pharma is a biopharmaceutical company focused on developing and commercializing innovative treatments for neurological disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.